drugset
drugset / Trial / NCT01982409

Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children

NCT01982409 ↗

Phase 4 Unknown 350 enrolled Changchun Changsheng Life Science and Technology Co., Ltd. Guangdong Provincial Institute of Biological Products And Materia Medica · collab
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to observe the persistence of protection, duration of protection, safety and breakthrough infection rates afforded by live attenuated varicella vaccine in children over a 5-year period.

Timeline

Start
2013-06
Primary completion
2018-01
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Live Attenuated Varicella Vaccine Vaccine — Other

Indications

chickenpox